Share Price and Basic Stock Data
Last Updated: January 3, 2026, 11:34 am
| PEG Ratio | 0.96 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Innovana Thinklabs Ltd operates in the IT Consulting & Software industry, showcasing a robust growth trajectory. In the fiscal year ending March 2025, the company reported sales of ₹103 Cr, reflecting a remarkable increase from ₹79 Cr in March 2023. This growth trajectory is consistent when looking at the trailing twelve months (TTM) sales, which stood at ₹120 Cr. Quarterly sales figures reveal fluctuations, with the highest quarterly sales recorded at ₹32 Cr in June 2025 and a slight dip to ₹22 Cr in March 2024. The overall trend indicates a positive reception of its services, likely driven by increasing demand for IT solutions. Additionally, a notable growth in operating profit margin (OPM) from 39% in March 2023 to 54% in March 2025 further underlines the company’s ability to effectively manage costs while enhancing revenue generation.
Profitability and Efficiency Metrics
Innovana Thinklabs Ltd has demonstrated strong profitability metrics, with a reported net profit of ₹45 Cr for the fiscal year ending March 2025, up from ₹27 Cr in March 2023. The net profit margin stood at an impressive 40.21% in March 2025, indicating effective cost management alongside revenue growth. The company’s return on equity (ROE) was recorded at 22.9%, showcasing efficient use of shareholders’ funds. Furthermore, the interest coverage ratio (ICR) stood at a robust 16.31x, indicating that the company comfortably meets its interest obligations. The cash conversion cycle (CCC) has improved markedly, declining to 197 days in March 2025 from 42 days in March 2023, reflecting enhanced operational efficiency. Despite the challenges of managing operational expenses, the company’s ability to maintain a high OPM of 54% underscores its competitive advantage in the IT sector.
Balance Sheet Strength and Financial Ratios
The financial stability of Innovana Thinklabs Ltd is evident in its balance sheet, with total assets reported at ₹346 Cr as of September 2025. The company’s reserves have significantly increased to ₹240 Cr, up from ₹91 Cr in March 2023, indicating a solid accumulation of retained earnings. With borrowings standing at ₹50 Cr, the total debt to equity ratio is a low 0.02x, highlighting the company’s conservative leverage strategy. The book value per share has risen to ₹100.22, reflecting a strong equity base per shareholder. The current ratio of 2.59x suggests that Innovana is well-positioned to cover its short-term liabilities, while the quick ratio of 2.11x reinforces this liquidity position. These financial ratios indicate a sound financial structure, positioning the company favorably for potential growth initiatives.
Shareholding Pattern and Investor Confidence
Innovana Thinklabs Ltd exhibits a stable shareholding pattern, with promoters holding 73.22% of the equity as of September 2025. This high level of promoter ownership often signals strong management confidence in the company’s future prospects. Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) have gradually increased their stakes, with FIIs at 0.84% and DIIs at 0.82%, reflecting growing interest from institutional investors. The number of shareholders has surged to 2,652, indicating a broadening base of retail investors. The gradual increase in institutional participation, alongside a consistent promoter shareholding, suggests a steady build-up of investor confidence in the company’s growth trajectory. However, the relatively low institutional holding may raise questions regarding the depth of market confidence, an aspect that the company may need to address to attract further investments.
Outlook, Risks, and Final Insight
Looking ahead, Innovana Thinklabs Ltd is positioned for continued growth owing to its strong financial fundamentals and operational efficiency. The increasing sales trajectory and profitability metrics indicate a favorable market position in the IT consulting sector. However, potential risks include market volatility, competition from established players, and the need for continuous innovation to meet evolving client demands. Additionally, the company’s reliance on a limited customer base could present vulnerabilities. If Innovana can leverage its strengths, such as high margins and effective cost management, it may capitalize on growth opportunities. Conversely, failure to adapt to market changes could hinder its progress. Ultimately, Innovana’s ability to balance growth with risk management will determine its long-term success in the competitive IT landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Visesh Infotecnics Ltd | 125 Cr. | 0.33 | / | 1.11 | 0.00 % | 2.21 % | 2.23 % | 1.00 | |
| Mudunuru Ltd | 59.2 Cr. | 18.7 | 18.7/4.43 | 0.20 | 0.00 % | 27.0 % | 90.7 % | 2.00 | |
| Naapbooks Ltd | 149 Cr. | 138 | 194/99.8 | 22.8 | 36.4 | 0.00 % | 23.6 % | 17.1 % | 10.0 |
| IB Infotech Enterprises Ltd | 38.3 Cr. | 299 | 310/140 | 27.4 | 26.7 | 0.33 % | 38.5 % | 35.4 % | 10.0 |
| Hit Kit Global Solutions Ltd | 5.71 Cr. | 1.06 | 1.73/0.91 | 2.47 | 0.00 % | 2.14 % | 2.15 % | 2.00 | |
| Industry Average | 20,271.35 Cr | 554.45 | 88.36 | 123.78 | 0.55% | 14.88% | 20.92% | 6.84 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 15 | 24 | 26 | 28 | 25 | 26 | 22 | 25 | 23 | 29 | 27 | 32 | 33 |
| Expenses | 11 | 12 | 15 | 14 | 14 | 13 | 14 | 13 | 11 | 12 | 12 | 16 | 18 |
| Operating Profit | 4 | 12 | 11 | 13 | 11 | 13 | 7 | 12 | 12 | 17 | 15 | 16 | 14 |
| OPM % | 29% | 51% | 42% | 48% | 45% | 49% | 34% | 49% | 54% | 57% | 56% | 50% | 43% |
| Other Income | 2 | 0 | 1 | 2 | 4 | 4 | 4 | 3 | 5 | 1 | 2 | 3 | 4 |
| Interest | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 |
| Profit before tax | 5 | 11 | 11 | 14 | 14 | 15 | 10 | 13 | 14 | 15 | 14 | 16 | 15 |
| Tax % | 39% | 6% | 10% | 27% | 21% | 24% | 12% | 27% | 26% | 24% | 22% | 22% | 23% |
| Net Profit | 3 | 11 | 10 | 10 | 11 | 11 | 9 | 10 | 11 | 12 | 12 | 13 | 13 |
| EPS in Rs | 1.38 | 5.23 | 4.86 | 4.89 | 5.41 | 5.51 | 4.17 | 4.95 | 5.32 | 5.70 | 5.56 | 6.32 | 6.19 |
Last Updated: January 1, 2026, 6:46 am
Below is a detailed analysis of the quarterly data for Innovana Thinklabs Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 33.00 Cr.. The value appears strong and on an upward trend. It has increased from 32.00 Cr. (Jun 2025) to 33.00 Cr., marking an increase of 1.00 Cr..
- For Expenses, as of Sep 2025, the value is 18.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 16.00 Cr. (Jun 2025) to 18.00 Cr., marking an increase of 2.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 16.00 Cr. (Jun 2025) to 14.00 Cr., marking a decrease of 2.00 Cr..
- For OPM %, as of Sep 2025, the value is 43.00%. The value appears to be declining and may need further review. It has decreased from 50.00% (Jun 2025) to 43.00%, marking a decrease of 7.00%.
- For Other Income, as of Sep 2025, the value is 4.00 Cr.. The value appears strong and on an upward trend. It has increased from 3.00 Cr. (Jun 2025) to 4.00 Cr., marking an increase of 1.00 Cr..
- For Interest, as of Sep 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 1.00 Cr..
- For Depreciation, as of Sep 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 2.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 15.00 Cr.. The value appears to be declining and may need further review. It has decreased from 16.00 Cr. (Jun 2025) to 15.00 Cr., marking a decrease of 1.00 Cr..
- For Tax %, as of Sep 2025, the value is 23.00%. The value appears to be increasing, which may not be favorable. It has increased from 22.00% (Jun 2025) to 23.00%, marking an increase of 1.00%.
- For Net Profit, as of Sep 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 13.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 6.19. The value appears to be declining and may need further review. It has decreased from 6.32 (Jun 2025) to 6.19, marking a decrease of 0.13.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:11 am
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 16 | 31 | 45 | 64 | 57 | 58 | 79 | 101 | 103 | 120 |
| Expenses | 14 | 20 | 31 | 40 | 40 | 32 | 48 | 56 | 47 | 58 |
| Operating Profit | 1 | 11 | 14 | 24 | 16 | 26 | 31 | 45 | 56 | 62 |
| OPM % | 8% | 36% | 31% | 38% | 28% | 45% | 39% | 45% | 54% | 51% |
| Other Income | 0 | 0 | 1 | 3 | 4 | 4 | 7 | 14 | 10 | 10 |
| Interest | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 4 | 4 |
| Depreciation | 0 | 0 | 1 | 1 | 1 | 3 | 4 | 4 | 7 | 8 |
| Profit before tax | 1 | 11 | 14 | 26 | 19 | 26 | 33 | 53 | 55 | 59 |
| Tax % | 38% | 29% | 24% | 16% | 18% | 18% | 16% | 22% | 25% | |
| Net Profit | 1 | 8 | 11 | 22 | 16 | 21 | 27 | 41 | 45 | 49 |
| EPS in Rs | 7.20 | 3.69 | 5.20 | 10.61 | 7.59 | 10.14 | 13.12 | 19.98 | 21.53 | 23.77 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 8% | 7% | 2% | 0% | 0% |
YoY Net Profit Growth
| Year | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 700.00% | 37.50% | 100.00% | -27.27% | 31.25% | 28.57% | 51.85% | 9.76% |
| Change in YoY Net Profit Growth (%) | 0.00% | -662.50% | 62.50% | -127.27% | 58.52% | -2.68% | 23.28% | -42.10% |
Innovana Thinklabs Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2017-2018 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 10% |
| 3 Years: | 22% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 16% |
| 3 Years: | 31% |
| TTM: | 14% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 59% |
| 3 Years: | 60% |
| 1 Year: | 6% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 25% |
| 3 Years: | 25% |
| Last Year: | 24% |
Last Updated: September 5, 2025, 7:40 am
Balance Sheet
Last Updated: December 4, 2025, 1:26 am
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.20 | 4 | 4 | 10 | 10 | 10 | 20 | 20 | 20 | 20 |
| Reserves | 1 | 14 | 25 | 40 | 56 | 76 | 91 | 143 | 185 | 240 |
| Borrowings | 2 | 0 | 1 | 1 | 1 | 15 | 12 | 23 | 44 | 50 |
| Other Liabilities | 3 | 12 | 43 | 72 | 70 | 57 | 48 | 23 | 28 | 35 |
| Total Liabilities | 6 | 30 | 72 | 122 | 137 | 158 | 171 | 209 | 278 | 346 |
| Fixed Assets | 1 | 9 | 13 | 12 | 14 | 28 | 27 | 30 | 59 | 81 |
| CWIP | 4 | 0 | 0 | 0 | 0 | 0 | 2 | 5 | 12 | 4 |
| Investments | 0 | 2 | 28 | 46 | 41 | 41 | 39 | 49 | 59 | 79 |
| Other Assets | 2 | 19 | 31 | 64 | 83 | 88 | 103 | 124 | 148 | 182 |
| Total Assets | 6 | 30 | 72 | 122 | 137 | 158 | 171 | 209 | 278 | 346 |
Below is a detailed analysis of the balance sheet data for Innovana Thinklabs Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 20.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 20.00 Cr..
- For Reserves, as of Sep 2025, the value is 240.00 Cr.. The value appears strong and on an upward trend. It has increased from 185.00 Cr. (Mar 2025) to 240.00 Cr., marking an increase of 55.00 Cr..
- For Borrowings, as of Sep 2025, the value is 50.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 44.00 Cr. (Mar 2025) to 50.00 Cr., marking an increase of 6.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 35.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 28.00 Cr. (Mar 2025) to 35.00 Cr., marking an increase of 7.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 346.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 278.00 Cr. (Mar 2025) to 346.00 Cr., marking an increase of 68.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 81.00 Cr.. The value appears strong and on an upward trend. It has increased from 59.00 Cr. (Mar 2025) to 81.00 Cr., marking an increase of 22.00 Cr..
- For CWIP, as of Sep 2025, the value is 4.00 Cr.. The value appears to be declining and may need further review. It has decreased from 12.00 Cr. (Mar 2025) to 4.00 Cr., marking a decrease of 8.00 Cr..
- For Investments, as of Sep 2025, the value is 79.00 Cr.. The value appears strong and on an upward trend. It has increased from 59.00 Cr. (Mar 2025) to 79.00 Cr., marking an increase of 20.00 Cr..
- For Other Assets, as of Sep 2025, the value is 182.00 Cr.. The value appears strong and on an upward trend. It has increased from 148.00 Cr. (Mar 2025) to 182.00 Cr., marking an increase of 34.00 Cr..
- For Total Assets, as of Sep 2025, the value is 346.00 Cr.. The value appears strong and on an upward trend. It has increased from 278.00 Cr. (Mar 2025) to 346.00 Cr., marking an increase of 68.00 Cr..
Notably, the Reserves (240.00 Cr.) exceed the Borrowings (50.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -1.00 | 11.00 | 13.00 | 23.00 | 15.00 | 11.00 | 19.00 | 22.00 | 12.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0 | 0 | 0 | 0 | 1 | 13 | 42 | 48 | 103 |
| Inventory Days | 0 | 0 | 0 | 0 | 593 | ||||
| Days Payable | 499 | ||||||||
| Cash Conversion Cycle | 0 | 0 | 0 | 0 | 1 | 13 | 42 | 48 | 197 |
| Working Capital Days | -36 | 7 | -221 | -277 | -238 | -243 | -69 | 78 | 124 |
| ROCE % | 100% | 58% | 63% | 31% | 31% | 26% | 32% | 27% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 21.81 | 20.13 | 26.17 | 20.46 | 15.48 |
| Diluted EPS (Rs.) | 21.81 | 20.13 | 26.17 | 20.46 | 15.48 |
| Cash EPS (Rs.) | 23.79 | 22.39 | 15.30 | 23.58 | 16.28 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 100.22 | 79.66 | 54.25 | 84.03 | 64.82 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 100.22 | 79.66 | 54.25 | 84.03 | 64.82 |
| Revenue From Operations / Share (Rs.) | 50.48 | 49.17 | 38.63 | 56.18 | 55.22 |
| PBDIT / Share (Rs.) | 32.47 | 28.92 | 18.53 | 29.24 | 19.61 |
| PBIT / Share (Rs.) | 28.98 | 26.74 | 16.59 | 26.61 | 18.50 |
| PBT / Share (Rs.) | 26.98 | 25.86 | 15.98 | 25.69 | 18.40 |
| Net Profit / Share (Rs.) | 20.30 | 20.21 | 13.37 | 20.94 | 15.17 |
| NP After MI And SOA / Share (Rs.) | 21.53 | 19.98 | 13.12 | 20.94 | 15.17 |
| PBDIT Margin (%) | 64.33 | 58.81 | 47.96 | 52.05 | 35.51 |
| PBIT Margin (%) | 57.40 | 54.37 | 42.96 | 47.36 | 33.50 |
| PBT Margin (%) | 53.45 | 52.58 | 41.36 | 45.73 | 33.32 |
| Net Profit Margin (%) | 40.21 | 41.09 | 34.60 | 37.28 | 27.47 |
| NP After MI And SOA Margin (%) | 42.65 | 40.62 | 33.97 | 37.28 | 27.47 |
| Return on Networth / Equity (%) | 21.48 | 25.07 | 24.19 | 24.92 | 23.40 |
| Return on Capital Employeed (%) | 23.89 | 30.38 | 27.67 | 27.48 | 27.90 |
| Return On Assets (%) | 15.86 | 19.62 | 15.70 | 13.11 | 11.32 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.02 | 0.01 |
| Total Debt / Equity (X) | 0.02 | 0.04 | 0.01 | 0.04 | 0.01 |
| Asset Turnover Ratio (%) | 0.42 | 0.53 | 0.47 | 0.24 | 0.31 |
| Current Ratio (X) | 2.59 | 1.97 | 0.78 | 1.39 | 1.15 |
| Quick Ratio (X) | 2.11 | 1.47 | 0.57 | 1.28 | 1.05 |
| Inventory Turnover Ratio (X) | 7.27 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 1.25 | 5.71 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 1.12 | 4.98 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 0.00 | 98.75 | 94.29 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 0.00 | 98.88 | 95.02 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 16.31 | 32.89 | 29.93 | 32.02 | 189.87 |
| Interest Coverage Ratio (Post Tax) (X) | 11.19 | 23.98 | 22.59 | 23.93 | 147.91 |
| Enterprise Value (Cr.) | 604.67 | 1111.90 | 634.46 | 417.61 | 54.87 |
| EV / Net Operating Revenue (X) | 5.84 | 11.03 | 8.01 | 7.25 | 0.96 |
| EV / EBITDA (X) | 9.08 | 18.75 | 16.70 | 13.93 | 2.73 |
| MarketCap / Net Operating Revenue (X) | 5.85 | 10.98 | 8.05 | 8.10 | 1.79 |
| Retention Ratios (%) | 0.00 | 98.74 | 94.28 | 0.00 | 0.00 |
| Price / BV (X) | 2.95 | 6.78 | 5.73 | 5.41 | 1.52 |
| Price / Net Operating Revenue (X) | 5.85 | 10.98 | 8.05 | 8.10 | 1.79 |
| EarningsYield | 0.07 | 0.03 | 0.04 | 0.04 | 0.15 |
After reviewing the key financial ratios for Innovana Thinklabs Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 21.81. This value is within the healthy range. It has increased from 20.13 (Mar 24) to 21.81, marking an increase of 1.68.
- For Diluted EPS (Rs.), as of Mar 25, the value is 21.81. This value is within the healthy range. It has increased from 20.13 (Mar 24) to 21.81, marking an increase of 1.68.
- For Cash EPS (Rs.), as of Mar 25, the value is 23.79. This value is within the healthy range. It has increased from 22.39 (Mar 24) to 23.79, marking an increase of 1.40.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 100.22. It has increased from 79.66 (Mar 24) to 100.22, marking an increase of 20.56.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 100.22. It has increased from 79.66 (Mar 24) to 100.22, marking an increase of 20.56.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 50.48. It has increased from 49.17 (Mar 24) to 50.48, marking an increase of 1.31.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 32.47. This value is within the healthy range. It has increased from 28.92 (Mar 24) to 32.47, marking an increase of 3.55.
- For PBIT / Share (Rs.), as of Mar 25, the value is 28.98. This value is within the healthy range. It has increased from 26.74 (Mar 24) to 28.98, marking an increase of 2.24.
- For PBT / Share (Rs.), as of Mar 25, the value is 26.98. This value is within the healthy range. It has increased from 25.86 (Mar 24) to 26.98, marking an increase of 1.12.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 20.30. This value is within the healthy range. It has increased from 20.21 (Mar 24) to 20.30, marking an increase of 0.09.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 21.53. This value is within the healthy range. It has increased from 19.98 (Mar 24) to 21.53, marking an increase of 1.55.
- For PBDIT Margin (%), as of Mar 25, the value is 64.33. This value is within the healthy range. It has increased from 58.81 (Mar 24) to 64.33, marking an increase of 5.52.
- For PBIT Margin (%), as of Mar 25, the value is 57.40. This value exceeds the healthy maximum of 20. It has increased from 54.37 (Mar 24) to 57.40, marking an increase of 3.03.
- For PBT Margin (%), as of Mar 25, the value is 53.45. This value is within the healthy range. It has increased from 52.58 (Mar 24) to 53.45, marking an increase of 0.87.
- For Net Profit Margin (%), as of Mar 25, the value is 40.21. This value exceeds the healthy maximum of 10. It has decreased from 41.09 (Mar 24) to 40.21, marking a decrease of 0.88.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 42.65. This value exceeds the healthy maximum of 20. It has increased from 40.62 (Mar 24) to 42.65, marking an increase of 2.03.
- For Return on Networth / Equity (%), as of Mar 25, the value is 21.48. This value is within the healthy range. It has decreased from 25.07 (Mar 24) to 21.48, marking a decrease of 3.59.
- For Return on Capital Employeed (%), as of Mar 25, the value is 23.89. This value is within the healthy range. It has decreased from 30.38 (Mar 24) to 23.89, marking a decrease of 6.49.
- For Return On Assets (%), as of Mar 25, the value is 15.86. This value is within the healthy range. It has decreased from 19.62 (Mar 24) to 15.86, marking a decrease of 3.76.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.02. This value is within the healthy range. It has decreased from 0.04 (Mar 24) to 0.02, marking a decrease of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.42. It has decreased from 0.53 (Mar 24) to 0.42, marking a decrease of 0.11.
- For Current Ratio (X), as of Mar 25, the value is 2.59. This value is within the healthy range. It has increased from 1.97 (Mar 24) to 2.59, marking an increase of 0.62.
- For Quick Ratio (X), as of Mar 25, the value is 2.11. This value exceeds the healthy maximum of 2. It has increased from 1.47 (Mar 24) to 2.11, marking an increase of 0.64.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.27. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 7.27, marking an increase of 7.27.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 1.25 (Mar 24) to 0.00, marking a decrease of 1.25.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 1.12 (Mar 24) to 0.00, marking a decrease of 1.12.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 98.75 (Mar 24) to 0.00, marking a decrease of 98.75.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 98.88 (Mar 24) to 0.00, marking a decrease of 98.88.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 16.31. This value is within the healthy range. It has decreased from 32.89 (Mar 24) to 16.31, marking a decrease of 16.58.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 11.19. This value is within the healthy range. It has decreased from 23.98 (Mar 24) to 11.19, marking a decrease of 12.79.
- For Enterprise Value (Cr.), as of Mar 25, the value is 604.67. It has decreased from 1,111.90 (Mar 24) to 604.67, marking a decrease of 507.23.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 5.84. This value exceeds the healthy maximum of 3. It has decreased from 11.03 (Mar 24) to 5.84, marking a decrease of 5.19.
- For EV / EBITDA (X), as of Mar 25, the value is 9.08. This value is within the healthy range. It has decreased from 18.75 (Mar 24) to 9.08, marking a decrease of 9.67.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 5.85. This value exceeds the healthy maximum of 3. It has decreased from 10.98 (Mar 24) to 5.85, marking a decrease of 5.13.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 98.74 (Mar 24) to 0.00, marking a decrease of 98.74.
- For Price / BV (X), as of Mar 25, the value is 2.95. This value is within the healthy range. It has decreased from 6.78 (Mar 24) to 2.95, marking a decrease of 3.83.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 5.85. This value exceeds the healthy maximum of 3. It has decreased from 10.98 (Mar 24) to 5.85, marking a decrease of 5.13.
- For EarningsYield, as of Mar 25, the value is 0.07. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.07, marking an increase of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Innovana Thinklabs Ltd:
- Net Profit Margin: 40.21%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 23.89% (Industry Average ROCE: 14.88%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 21.48% (Industry Average ROE: 20.92%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 11.19
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.11
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 17.8 (Industry average Stock P/E: 88.36)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.02
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 40.21%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Consulting & Software | Plot No. D-41, Patrakar Colony, Near Jawahar Nagar, Jaipur Rajasthan 302004 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Chandan Garg | Chairman & Managing Director |
| Mr. Kapil Garg | Whole Time Director |
| Ms. Riya Sharma | Independent Director |
| Mr. Hemant Koushik | Independent Director |
| Mr. Amritanshu Balani | Independent Director |
FAQ
What is the intrinsic value of Innovana Thinklabs Ltd?
Innovana Thinklabs Ltd's intrinsic value (as of 05 January 2026) is ₹422.42 which is 0.34% higher the current market price of ₹421.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹869 Cr. market cap, FY2025-2026 high/low of ₹650/270, reserves of ₹240 Cr, and liabilities of ₹346 Cr.
What is the Market Cap of Innovana Thinklabs Ltd?
The Market Cap of Innovana Thinklabs Ltd is 869 Cr..
What is the current Stock Price of Innovana Thinklabs Ltd as on 05 January 2026?
The current stock price of Innovana Thinklabs Ltd as on 05 January 2026 is ₹421.
What is the High / Low of Innovana Thinklabs Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Innovana Thinklabs Ltd stocks is ₹650/270.
What is the Stock P/E of Innovana Thinklabs Ltd?
The Stock P/E of Innovana Thinklabs Ltd is 17.8.
What is the Book Value of Innovana Thinklabs Ltd?
The Book Value of Innovana Thinklabs Ltd is 127.
What is the Dividend Yield of Innovana Thinklabs Ltd?
The Dividend Yield of Innovana Thinklabs Ltd is 0.00 %.
What is the ROCE of Innovana Thinklabs Ltd?
The ROCE of Innovana Thinklabs Ltd is 25.6 %.
What is the ROE of Innovana Thinklabs Ltd?
The ROE of Innovana Thinklabs Ltd is 22.9 %.
What is the Face Value of Innovana Thinklabs Ltd?
The Face Value of Innovana Thinklabs Ltd is 10.0.